These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 6118217)

  • 1. [A new drug combination: metipranolol with butizide in the treatment of arterial hypertension].
    De Cesaris R; Balestrazzi M; Procaccio P; Dell'Orco M
    Clin Ter; 1981 Oct; 99(1):43-7. PubMed ID: 6118217
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combination therapy of arterial hypertension].
    von Manteuffel GE; Ebel H; Zehner J
    Med Klin; 1980 Apr; 75(8):297-302. PubMed ID: 6104777
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antihypertensive therapy with a fixed combination of beta receptor blockers and diuretics].
    Kolloch R; Overlack A; Stumpe KO
    Ther Ggw; 1979 Oct; 118(10):1517-28. PubMed ID: 40314
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of the antihypertensive effect of metipranolol, butizide and torrat in Kenyan Africans.
    Obel AO; Gitau W
    East Afr Med J; 1981 Nov; 58(11):867-71. PubMed ID: 6122555
    [No Abstract]   [Full Text] [Related]  

  • 5. [Potassium canrenoate and the combination of potassium canrenoate-butizide in the therapy of light to moderate arterial hypertension].
    Morabito S; Fabiano M; Puliti M; Palumbo R; Marinelli R; Simonetti BM; Pierucci A
    Clin Ter; 1992 Jul; 141(7):23-8. PubMed ID: 1505173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M; Richter WO; Schwandt P; Holzgreve H
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic equivalent of a single and divided daily dose of 2 Tri-Torrat coated tablets].
    Teufel W; Bartsch W; Glocke M; Häcker W
    MMW Munch Med Wochenschr; 1984 Feb; 126(7):181-4. PubMed ID: 6143259
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of a study with the antihypertensive agent Torrat].
    Werning C
    Ther Ggw; 1978 Dec; 117(12):1924-9. PubMed ID: 31703
    [No Abstract]   [Full Text] [Related]  

  • 9. Recommendations from the Canadian Hypertension Society Consensus Conference on the Pharmacologic Treatment of Hypertension.
    Myers MG; Carruthers SG; Leenen FH; Haynes RB
    CMAJ; 1989 May; 140(10):1141-6. PubMed ID: 2565758
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antihypertensive first-line and add-on treatment with a fixed controlled release combination of metoprololsuccinate/hydrochlorothiazide. Prospective doctor's office observational study in 14,964 patients].
    Hildemann SK; Fischer HM; Bohlscheid V; Pittrow D
    MMW Fortschr Med; 2003 Apr; 145(14):42. PubMed ID: 15072279
    [No Abstract]   [Full Text] [Related]  

  • 11. [The use of the cardioselective adrenergic beta 1-blockader cordanum in the treatment of arterial hypertension].
    Zonis BIa; Brin VB
    Ter Arkh; 1983; 55(5):81-3. PubMed ID: 6137077
    [No Abstract]   [Full Text] [Related]  

  • 12. [Updating hypotensive therapy, especially with beta-blocking agents].
    Ferrara E; Mantovani M; Giugni R
    Clin Ter; 1981 Sep; 98(5):561-7. PubMed ID: 6118216
    [No Abstract]   [Full Text] [Related]  

  • 13. [Combined use of antihypertensive agents and treatment of high blood pressure].
    Orita Y; Fujiwara Y; Kitamura E
    Nihon Rinsho; 1985 May; 43(5):1000-5. PubMed ID: 2863401
    [No Abstract]   [Full Text] [Related]  

  • 14. Antihypertensive and hypokalemic effects of isobutyl hydrochlorothiazide alone and in combination with spironolactone.
    Lochaya S; Suvachittanont O; Triyanond K
    J Med Assoc Thai; 1985 Aug; 68(8):399-407. PubMed ID: 3906011
    [No Abstract]   [Full Text] [Related]  

  • 15. Some aspects of the management of hypertension. 1. General considerations.
    Rowe WS
    Med J Aust; 1975 Feb; 1(8):237-9. PubMed ID: 48180
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tiazides and betablockers in the treatment of hypertension].
    Jiménez Plata MC; Castillo Ferrando JR; Torelló Iserte J; Merino Kolly N
    Rev Esp Cardiol; 2000 Sep; 53(9):1301-2. PubMed ID: 11203361
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hypotensive effect of saluretics].
    Gobbi A; Reguzzoni G; Bonzi G
    Clin Ter; 1982 Feb; 100(4):375-81. PubMed ID: 7083786
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacotherapy of essential hypertension.
    Duhme DW; Greenblatt DJ; Miller RR
    Am J Hosp Pharm; 1975 May; 32(5):508-16. PubMed ID: 238388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of arterial hypertension. Clinico-therapeutical aspects of a new association: potassium cancreonate of altizide-rescinnamine].
    Restivo O; Sindoni G; Ballati S; Foti V
    Minerva Cardioangiol; 1973 Sep; 21(9):585-604. PubMed ID: 4147632
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy of arterial hypertension of renal origin].
    Schena FP
    Clin Ter; 1982 Apr; 101(1):87-93. PubMed ID: 6123403
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.